Pope Francis rests in hospital as Vatican and Holy Year marches on without him
Pope Francis continued his recovery from double pneumonia on Saturday as the Vatican machinery and Holy Year celebrations marched on without him, this weekend dedicated to the Catholic Church's volunteers.
Francis was continuing his respiratory and physical therapy after a quiet, restful night, the Vatican said.
The 88-year-old pope, who has chronic lung disease and had part of one lung removed as a young man, entered his fourth week at Rome's Gemelli hospital with his condition stabilized following a few bouts of acute respiratory crises.
In his absence, the Vatican's day-to-day operations continued, with Cardinal Pietro Parolin celebrating Mass for a pro-life group in St. Peter's Basilica. At the start, Parolin delivered a message from the pope from the hospital on the need to protect life, from birth to natural death.
In the message, dated March 5 and addressed to the Movement for Life, which seeks to provide women with alternatives to abortion, Francis encouraged the faithful to promote pro-life activities not just for the unborn, but 'for the elderly, no longer independent or the incurably ill.'
Later Saturday, another cardinal closely associated with Francis' papacy, Canadian Cardinal Michael Czerny, presides over the nightly recitation of prayers for Francis. Czerny then returns on Sunday to celebrate the Holy Year Mass for volunteers that Francis was supposed to have celebrated.
On Friday, Francis spent 20 minutes in the Gemelli hospital chapel, praying and doing some work in between rest and respiratory and physical therapy, the Vatican said. A medical update was expected later Saturday.
Francis has been using high flows of supplemental oxygen to help him breathe during the day and a noninvasive mechanical ventilation mask at night.
Doctors not involved in his care said after three weeks of acute care in the hospital for double pneumonia, they would have hoped to have seen improvement. While he has stabilized, they warned that he was increasingly at risk of secondary infections the longer he remains hospitalized. Additionally, Francis had episodes of acute respiratory failure earlier this week and underwent bronchoscopies to suction mucus from his lungs.
'He's had respiratory failure and they were not able to liberate him from the hospital in the first three weeks. And therefore I think you'd say this does look concerning, perhaps more concerning than it did right at the beginning,' said Dr. Andrew Chadwick, a respiratory and intensive care specialist at Oxford University Hospitals in England.
Dr. Jeffrey Millstein, a clinical assistant professor of internal medicine at the University of Pennsylvania, said it wasn't shocking that Francis hadn't improved in three weeks, and that it was encouraging he was able to breathe part of the day with just a nasal tube of high-flow oxygen.
But he said that the pope's condition certainly was 'a precarious, touch and go kind of situation' and that recovery, while still possible, would be a long process.
Going forward, 'I just would be looking for no new setbacks,' he said. 'I think as long as he is dealing with the current issues and he's just making incremental progress, that would be great.'
Francis was hospitalized Feb. 14 for what was then just a bad case of bronchitis. The infection progressed into a complex respiratory tract infection and double pneumonia that has sidelined Francis for the longest period of his 12-year papacy and raised questions about the future.
___
Associated Press religion coverage receives support through the AP's collaboration with The Conversation US, with funding from Lilly Endowment Inc. The AP is solely responsible for this content.
Download the FREE WPXI News app for breaking news alerts.
Follow Channel 11 News on Facebook and Twitter. | Watch WPXI NOW
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Trade bill could trigger 'race to the bottom' in health standards, health groups warn
OTTAWA — Anti-smoking groups are warning the Carney government that its legislation to eliminate interprovincial trade barriers could undermine health standards unless it's amended to add new safeguards. The legislation, which the governing Liberals intend to push quickly through the House of Commons next week, looks to do two things — break down interprovincial barriers to trade and labour mobility and speed up approvals for major industrial projects, such as mines, ports and pipelines. The bill would allow provincial standards to displace federal ones to make it easier to sell Canadian-made goods within the country. But Rob Cunningham, senior policy analyst at the Canadian Cancer Society, said the current wording could lead to unintended consequences since provincial rules are sometimes weaker. He warns that, for example, it could prompt the return of products banned by federal regulation, such as those containing asbestos. "There's a federal measure banning asbestos in products, but provinces allow up to a certain per cent of asbestos in products," he said. "So that would mean that despite asbestos being banned in products for some years now, you could have asbestos return to products. That's not good." He also suggested the legislation could give tobacco companies space to bring back menthol or flavoured cigarettes, something that "shouldn't be happening." Cunningham said the bill should be changed to exempt federal health and environment standards and noted multilateral trade agreements typically contain such clauses. 'We are worried the tobacco (and) vape industry could take advantage of a less strict provincial standard to erode a stronger federal regulation that is protecting the health of Canadians across the country,' said Manuel Arango, vice-president of policy and advocacy at the Heart and Stroke Foundation. Ottawa could still create an exception for health through regulations after the bill is passed. It has not yet indicated it will do so. Cynthia Callard, head of Physicians for a Smoke-Free Canada, said she worries about the bill being rushed through Parliament since the devil "will likely be in the details in the regulations." "If these are not well constructed, there is a decided risk of health protection becoming collateral damage of a push for greater economic activity," she said. "Provincial and federal governments share jurisdiction for (health and environmental) issues, which is why it is important that there is a legal shield against a race to the bottom when it comes to protective regulations. I do not see this in the bill." The Bloc Québécois, NDP and Green Party are accusing Prime Minister Mark Carney's government of trying to ram the bill through Parliament too quickly without sufficient study. Carney promised to eliminate federal policies that act as a barrier to interprovincial trade by Canada Day. The Liberal government has not yet responded to requests for comment. On Friday, Intergovernmental Affairs Minister Dominic LeBlanc laid out the economic case for the trade aspects of the bill during debate in the House of Commons. He said the bill will remove "useless costs" and "regulatory confusion" that "hobble Canadians' ability to trade, connect and work wherever opportunity calls across our country." 'If a good is produced in compliance with provincial standards, it can move throughout the entire country without again having to go up against federal standards,' he said. He pointed to various levels of energy efficiency requirements that can stop products from being sold across provincial lines. He said an Ontario-made product that meets the province's "stringent energy efficiency requirements" could still be blocked from being sold in Quebec or Manitoba if it also does not meet federal standards. This report by The Canadian Press was first published June 13, 2025. Kyle Duggan, The Canadian Press Sign in to access your portfolio
Yahoo
5 hours ago
- Yahoo
Breast Cancer Canada Applauds Federal Commitment to Modernize Preventive Health Guidelines
Inclusion of experts, patient voices, and equity-focused policy reflects priorities long championed by Breast Cancer Canada TORONTO, June 13, 2025--(BUSINESS WIRE)--Breast Cancer Canada proudly celebrates the federal government's response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is more equitable, expert-informed, and responsive to real-world care. "These systematic changes will save lives," said Kimberly Carson, CEO of Breast Cancer Canada. "We commend Canada's Federal Health Minister Marjorie Michel for making this a priority so early in her mandate, and we thank former Health Minister Mark Holland for working so closely with Breast Cancer Canada during his tenure. This milestone reflects years of dedicated advocacy. Bringing expert voices into task force decision-making is a long-overdue step toward ensuring that both science and lived experience shape public policy for Canadians." The EER outlines recommendations, including stronger integration of subject matter experts, patient and public voices, and structured provincial input in guideline development. For Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance—a national coalition of breast cancer experts—the report validates their persistent calls to reform how health guidance is developed and delivered in Canada. It also affirms that advocacy works: the federal government listened to patients and advocates calling for change. This report embodies the transformative shift Breast Cancer Canada has relentlessly advocated for: expert-led, patient-centred, and equity-driven care informed by Canadian data and research. It signals a new era in Canadian breast cancer policy, one grounded in a national commitment to access for all. "This report is a breakthrough," said Kimberly Carson, CEO of Breast Cancer Canada. "It recognizes that science and lived experience must work together to shape public health guidance. These recommendations reflect what Breast Cancer Canada, researchers, clinicians, and patients have been saying for years." Founded by Breast Cancer Canada in 2023, REAL Canadian Breast Cancer Alliance brings together leading clinicians, patient advocates and data from across the country to advance evidence-based, equitable, and patient-informed breast cancer care. REAL Alliance was established to ensure that the latest research reaches patients faster and to help establish equitable, national standards of care for breast cancer. Breast Cancer Canada is actively addressing the critical gap in Canadian-specific data by collecting and analyzing breast cancer outcomes across all stages and subtypes, with a focus on race, age, and geographic location. "We are especially encouraged to see a formal shift toward expert engagement," said Shaniah Leduc, Chair of Breast Cancer Canada's Board of Directors. "Guidelines that impact patient outcomes must include disease-specific expertise. It's not just about input—it's about equity and access. Science moves quickly, and lives are affected when guidelines lag behind. A commitment to living guidelines ensures Canadians benefit from the most current knowledge in real-time." "As someone whose survival depended on timely diagnosis and access to targeted treatment, I know firsthand the power of evidence-based care," said Kim MacDonald, breast cancer survivor and advocate with Breast Cancer Canada. "The recommendations released today are long overdue. Including expert insight and patient experience in national health guidance isn't just the right thing to do—it's what saves lives. My story could have ended differently without access to the testing and treatment I needed. Every Canadian deserves equity and access." As the report notes, current guideline development in Canada is fragmented and often lacks the flexibility to reflect provincial realities or incorporate diverse forms of knowledge. The recommendations call for a pan-Canadian coordination hub and better integration with provincial screening programs, quality councils, and implementation bodies. "When evidence, expert insight, and lived experience come together, patients benefit," Carson added. "We look forward to seeing these recommendations put into action and continuing our role in ensuring breast cancer care is equitable, evidence-based, and patient-informed." Key Takeaways from the External Expert Review of Canada's Preventive Health Guidelines: Formal inclusion of clinical subject matter experts in the Task Force's working groups to strengthen evidence interpretation and disease-specific expertise Structured engagement of patients and community members, particularly from underrepresented groups, to bring real-world lived experience into national guideline development Equity-focused topic selection and public accountability, ensuring preventive guidance addresses the realities of all people in Canada, especially those from equity-denied populations Contextualizable and coordinated guidelines, enabling provinces and territories to implement evidence-based recommendations in a way that fits their own systems and structures A phased transition to living guidelines, so recommendations keep pace with science and practice in real-time Breast Cancer Canada remains a committed partner in this modernization effort, with ongoing investments in personalized screening research and the REAL Alliance—a multi-disciplinary expert body established to accelerate breast cancer progress through national collaboration. Breast Cancer Canada is a national charity dedicated to saving lives through science. Focused exclusively on breast cancer research, Breast Cancer Canada funds programs that advance earlier detection, better treatment, and improved outcomes for everyone affected by the disease. For more information, visit About Breast Cancer Canada Breast Cancer Canada is a national charity focused exclusively on breast cancer research, education, and awareness. Dedicated to advancing science that leads to earlier detection, more precise treatments, improved access to care, and better outcomes, the organization ensures that lived experience is reflected in research priorities. With no government funding, all progress is made possible through the generosity of donors. To learn more, visit About REAL Canadian Breast Cancer Alliance REAL (Research Excellence + Active Leadership) Canadian Breast Cancer Alliance is a national coalition of clinical and academic experts driving improvements in breast cancer care. Formed in 2023 by Breast Cancer Canada, REAL Alliance produces annual evidence-based clinical recommendations through a structured, consensus-driven process that reflects the latest in research and innovation. REAL Alliance is committed to advancing national standards of care and ensuring all Canadians benefit from the best available science. To learn more, visit View source version on Contacts Media Megan DunscombeBreast Cancer Canadamdunscombe@
Business Wire
5 hours ago
- Business Wire
Breast Cancer Canada Applauds Federal Commitment to Modernize Preventive Health Guidelines
TORONTO--(BUSINESS WIRE)--Breast Cancer Canada proudly celebrates the federal government's response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is more equitable, expert-informed, and responsive to real-world care. 'These systematic changes will save lives,' said Kimberly Carson, CEO of Breast Cancer Canada. 'We commend Canada's Federal Health Minister Marjorie Michel for making this a priority so early in her mandate, and we thank former Health Minister Mark Holland for working so closely with Breast Cancer Canada during his tenure. This milestone reflects years of dedicated advocacy. Bringing expert voices into task force decision-making is a long-overdue step toward ensuring that both science and lived experience shape public policy for Canadians.' The EER outlines recommendations, including stronger integration of subject matter experts, patient and public voices, and structured provincial input in guideline development. For Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance—a national coalition of breast cancer experts—the report validates their persistent calls to reform how health guidance is developed and delivered in Canada. It also affirms that advocacy works: the federal government listened to patients and advocates calling for change. This report embodies the transformative shift Breast Cancer Canada has relentlessly advocated for: expert-led, patient-centred, and equity-driven care informed by Canadian data and research. It signals a new era in Canadian breast cancer policy, one grounded in a national commitment to access for all. 'This report is a breakthrough,' said Kimberly Carson, CEO of Breast Cancer Canada. 'It recognizes that science and lived experience must work together to shape public health guidance. These recommendations reflect what Breast Cancer Canada, researchers, clinicians, and patients have been saying for years.' Founded by Breast Cancer Canada in 2023, REAL Canadian Breast Cancer Alliance brings together leading clinicians, patient advocates and data from across the country to advance evidence-based, equitable, and patient-informed breast cancer care. REAL Alliance was established to ensure that the latest research reaches patients faster and to help establish equitable, national standards of care for breast cancer. Breast Cancer Canada is actively addressing the critical gap in Canadian-specific data by collecting and analyzing breast cancer outcomes across all stages and subtypes, with a focus on race, age, and geographic location. 'We are especially encouraged to see a formal shift toward expert engagement,' said Shaniah Leduc, Chair of Breast Cancer Canada's Board of Directors. 'Guidelines that impact patient outcomes must include disease-specific expertise. It's not just about input—it's about equity and access. Science moves quickly, and lives are affected when guidelines lag behind. A commitment to living guidelines ensures Canadians benefit from the most current knowledge in real-time.' 'As someone whose survival depended on timely diagnosis and access to targeted treatment, I know firsthand the power of evidence-based care,' said Kim MacDonald, breast cancer survivor and advocate with Breast Cancer Canada. 'The recommendations released today are long overdue. Including expert insight and patient experience in national health guidance isn't just the right thing to do—it's what saves lives. My story could have ended differently without access to the testing and treatment I needed. Every Canadian deserves equity and access.' As the report notes, current guideline development in Canada is fragmented and often lacks the flexibility to reflect provincial realities or incorporate diverse forms of knowledge. The recommendations call for a pan-Canadian coordination hub and better integration with provincial screening programs, quality councils, and implementation bodies. 'When evidence, expert insight, and lived experience come together, patients benefit,' Carson added. 'We look forward to seeing these recommendations put into action and continuing our role in ensuring breast cancer care is equitable, evidence-based, and patient-informed.' Key Takeaways from the External Expert Review of Canada's Preventive Health Guidelines: Formal inclusion of clinical subject matter experts in the Task Force's working groups to strengthen evidence interpretation and disease-specific expertise Structured engagement of patients and community members, particularly from underrepresented groups, to bring real-world lived experience into national guideline development Equity-focused topic selection and public accountability, ensuring preventive guidance addresses the realities of all people in Canada, especially those from equity-denied populations Contextualizable and coordinated guidelines, enabling provinces and territories to implement evidence-based recommendations in a way that fits their own systems and structures A phased transition to living guidelines, so recommendations keep pace with science and practice in real-time Breast Cancer Canada remains a committed partner in this modernization effort, with ongoing investments in personalized screening research and the REAL Alliance—a multi-disciplinary expert body established to accelerate breast cancer progress through national collaboration. Breast Cancer Canada is a national charity dedicated to saving lives through science. Focused exclusively on breast cancer research, Breast Cancer Canada funds programs that advance earlier detection, better treatment, and improved outcomes for everyone affected by the disease. For more information, visit About Breast Cancer Canada Breast Cancer Canada is a national charity focused exclusively on breast cancer research, education, and awareness. Dedicated to advancing science that leads to earlier detection, more precise treatments, improved access to care, and better outcomes, the organization ensures that lived experience is reflected in research priorities. With no government funding, all progress is made possible through the generosity of donors. To learn more, visit About REAL Canadian Breast Cancer Alliance REAL (Research Excellence + Active Leadership) Canadian Breast Cancer Alliance is a national coalition of clinical and academic experts driving improvements in breast cancer care. Formed in 2023 by Breast Cancer Canada, REAL Alliance produces annual evidence-based clinical recommendations through a structured, consensus-driven process that reflects the latest in research and innovation. REAL Alliance is committed to advancing national standards of care and ensuring all Canadians benefit from the best available science. To learn more, visit
